PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 112 filers reported holding PHATHOM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $94,011,000 | +17.6% | 11,141 | +89.7% | 0.05% | +134.8% |
| Q1 2022 | $79,940,000 | -19.6% | 5,874 | +16.1% | 0.02% | -4.2% |
| Q4 2021 | $99,487,000 | -38.7% | 5,058 | 0.0% | 0.02% | -38.5% |
| Q3 2021 | $162,356,000 | +68.1% | 5,058 | +78.3% | 0.04% | +77.3% |
| Q2 2021 | $96,598,000 | +30.8% | 2,837 | +44.3% | 0.02% | +4.8% |
| Q1 2021 | $73,840,000 | -15.4% | 1,966 | -25.2% | 0.02% | -19.2% |
| Q4 2020 | $87,265,000 | -9.4% | 2,627 | 0.0% | 0.03% | -7.1% |
| Q3 2020 | $96,327,000 | +5.4% | 2,627 | -5.4% | 0.03% | +16.7% |
| Q2 2020 | $91,385,000 | +14.1% | 2,777 | -10.5% | 0.02% | +9.1% |
| Q1 2020 | $80,090,000 | – | 3,102 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $40,675,000 | 10.18% |
| FRAZIER MANAGEMENT LLC | 5,827,415 | $114,625,000 | 8.82% |
| Abingworth LLP | 1,203,135 | $23,606,000 | 5.72% |
| RA Capital Management | 3,115,008 | $61,272,000 | 1.08% |
| Avidity Partners Management LP | 1,896,000 | $37,294,000 | 0.79% |
| StepStone Group LP | 422,085 | $8,302,000 | 0.47% |
| Summit Rock Advisors, LP | 34,100 | $671,000 | 0.40% |
| Parkman Healthcare Partners LLC | 77,481 | $1,524,000 | 0.34% |
| Rhenman & Partners Asset Management AB | 186,210 | $3,624,000 | 0.24% |
| Ikarian Capital, LLC | 74,560 | $1,467,000 | 0.22% |